How Can NMR Help To Identify Novel Cervical Cancer Treatments?
Cervical cancer is the fourth most commonly occurring cancer in women and the eighth most commonly occurring cancer overall. Globally, there were over 500,000 new cases in 20181.
Virtually all cervical cancers are associated with Human papillomaviruses (HPVs)2. However, the presence of HPV does not mean a woman will develop cervical cancer. HPV infection will increase the susceptibility to developing cervical cancer, but other environmental factors are required for the cancer to develop.
Treatment to prevent cervical cancer spreading is required as soon as possible to avoid a more severe disease course. This is usually achieved by ablation of the abnormal cells by surgical excision, chemotherapy, or cryotherapy. Although effective, such procedures are not ideal due to the excessive tissue damage that can occur. Consequently, there is ongoing research to develop an efficient but safer alternative.
No hay comentarios:
Publicar un comentario